Monoclonal Gammopathy of Undetermined Significance (MGUS)Symptoms, Doctors, Treatments, Advances & More
Learn About Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Monoclonal gammopathy of undetermined significance
- MGUS
Dana-Farber Brigham Cancer Center
Elizabeth O'donnell is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. O'donnell is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Orchiectomy, and Bone Marrow Aspiration. Dr. O'donnell is board certified in Internal Medicine and Medical Oncology.
Vince Lombardi Cancer Clinic
Demet Yasar is a Hematologist practicing medicine in Green Bay, Wisconsin. Dr. Yasar is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 51 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS). Dr. Yasar is board certified in American Board Of Internal Medicine, Hematology.
Each patient is unique and therapy needs to be tailored to an individual's personal needs and goals. Dr. Frank is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Anemia, Myelodysplastic Syndrome (MDS), and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Frank is board certified in Hematology & Oncology.
Summary: The goal of this study is to find markers that may help to predict why some patients who have monoclonal gammopathy of unknown significance (MGUS) or smoldering multiple myeloma (SMM) that have no signs or symptoms of disease (asymptomatic) develop multiple myeloma, while others do not. Studying markers such as age, level of proteins in blood, percent of abnormal blood cells in the bone marrow, ge...
Summary: The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substa...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center